Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse
Primary Purpose
Pelvic Organ Prolapse
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ISFF
Sponsored by
About this trial
This is an interventional treatment trial for Pelvic Organ Prolapse focused on measuring pelvic organ prolapse
Eligibility Criteria
Inclusion Criteria:
- Candidates with symptomatic pelvic organ prolapse of POP-Q Stage II or more, suitable for surgical repair.
- Vaginal hysterectomy and anti-incontinence procedures could be performed concurrently.
- Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires.
Exclusion Criteria:
- Previous repair of pelvic organ prolapse involving insertion of mesh.
- Experimental drug or experimental medical device within 3 months prior to the planned procedure.
- Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared.
- Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery.
- History of chemotherapy or pelvic radiation therapy.
- Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease, multiple sclerosis, spinal cord injury or trauma).
- Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis, endometriosis, coccydynia, vulvodynia).
- Nursing or pregnant or intends future pregnancy.
- Chronic cough not well-controlled.
- BMI ≥ 30.
- In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.
Sites / Locations
- Foshan Maternal and Child Health HospitalRecruiting
- The third Affiliated Hospital of Zhengzhou UniversityRecruiting
- Affiliated Shengjing Hospital of China Medical UniversityRecruiting
- Peking Union Medical College HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
ISFF
Arm Description
The patients performed ischia spinous fascia fixation surgery.
Outcomes
Primary Outcome Measures
Anatomical improvement according to POP-Q Score
Anatomical improvement according to POP-Q Score
Anatomical improvement according to POP-Q Score
Anatomical improvement according to POP-Q Score
Secondary Outcome Measures
Hospital data including operative time, estimated blood loss, length of stay, postoperative mortality, time of voiding recovery
Full Information
NCT ID
NCT01760603
First Posted
December 25, 2012
Last Updated
January 2, 2013
Sponsor
Peking Union Medical College Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01760603
Brief Title
Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse
Official Title
A Prospective,Multicenter Pilot Study to Evaluate the Clinical Performance of the Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse.
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Unknown status
Study Start Date
December 2012 (undefined)
Primary Completion Date
December 2014 (Anticipated)
Study Completion Date
December 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Peking Union Medical College Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Pelvic organ prolapse is a common problem. The primary treatment is surgery. Ischia spinous fascia fixation procedure is developed in China for vaginal apex fixation with native tissue.
This study is designed to determine the effectiveness and safety of ischia spinous fascia fixation procedure for the treatment of pelvic organ prolapse stage III.
Patients enrolled into the study will be followed up for up to 3 years after surgery. Evaluation will take place during surgery and postoperative visit. Stage of prolapse before and after surgery, patient satisfaction through quality of life and sexual function questionnaires before and after surgery, and peri-operative complication rates will be evaluated.
Detailed Description
Pelvic Organ prolapse (a feeling of bulge in the vagina) may cause some distressing symptoms such as loss of control of the bowel or bladder, and may also cause problems with patient's sex life. An ideal procedure for vaginal apical support should provide a durable suspension, have minimal complications, and not affect sexual or visceral function.
Ischia spinous fascia fixation procedure is developed in China. It is a transvaginal procedure used for restoring the vaginal apex support with native tissue. Clinical practice showed that it was safe, efficient and cost-effective. Recurrent rate after 1 year follow-up was about 10%, and quality of life improved significantly from the baseline.
The purpose of this multicenter, prospective study is to evaluate the effectiveness and safety of this procedure in the treatment of symptomatic pelvic organ prolapse.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pelvic Organ Prolapse
Keywords
pelvic organ prolapse
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
75 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
ISFF
Arm Type
Experimental
Arm Description
The patients performed ischia spinous fascia fixation surgery.
Intervention Type
Procedure
Intervention Name(s)
ISFF
Intervention Description
Ischia spinous fascia fixation surgery was performed on patient with pelvic organ prolapse.
Primary Outcome Measure Information:
Title
Anatomical improvement according to POP-Q Score
Time Frame
6 weeks
Title
Anatomical improvement according to POP-Q Score
Time Frame
1 year
Title
Anatomical improvement according to POP-Q Score
Time Frame
2 years
Title
Anatomical improvement according to POP-Q Score
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Hospital data including operative time, estimated blood loss, length of stay, postoperative mortality, time of voiding recovery
Time Frame
At discharge, an expected average of 5 days after operation
Other Pre-specified Outcome Measures:
Title
Presence/absence of complications (composite score)
Description
The occurrence (in the per-operative phase or within 6 weeks post-op) of at least one of the following: 1) bleeding complications; 2) infectious complications; 3) any wound caused by a surgeon movement: bladder, ureteral, or vascular injuries; 4)medical complications: deep vein thrombosis, pulmonary embolism and etc.Complications will be categorized using the Dindo surgical complication grading scale
Time Frame
Up to 6 weeks
Title
Change from baseline in PFIQ-7 scores
Time Frame
6 month, 1 year, 2 years and 3 years
Title
n subjects sexually active at baseline, assessment of sexual function using PISQ-12 (mean scores and change from baseline)
Time Frame
6 months, 1 year, 2 years and 3 years
Title
Subject global impression assessed on a 5 point Likert scale
Time Frame
6 months, 1 year, 2 years, 3 years
Title
Presence/absence of complications (composite score)
Description
Long-term negative outcomes of the surgical procedure will also be recorded until 3 years after surgery. For example, de novo urinary incontinence, de novo dyspareunia and overall failure rate. Complications will be categorized using the Dindo surgical complication grading scale.
Time Frame
up to 3 years
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Candidates with symptomatic pelvic organ prolapse of POP-Q Stage II or more, suitable for surgical repair.
Vaginal hysterectomy and anti-incontinence procedures could be performed concurrently.
Agrees to participate in the study, including completion of all study-related procedures, evaluations and questionnaires.
Exclusion Criteria:
Previous repair of pelvic organ prolapse involving insertion of mesh.
Experimental drug or experimental medical device within 3 months prior to the planned procedure.
Active genital, urinary or systemic infection at the time of the surgical procedure. Surgery may be delayed in such subjects until the infection is cleared.
Coagulation disorder or on therapeutic anticoagulant therapy at the time of surgery.
History of chemotherapy or pelvic radiation therapy.
Systemic disease known to affect bladder or bowel function (e.g. Parkinson's disease, multiple sclerosis, spinal cord injury or trauma).
Current evaluation or treatment for chronic pelvic pain (e.g. interstitial cystitis, endometriosis, coccydynia, vulvodynia).
Nursing or pregnant or intends future pregnancy.
Chronic cough not well-controlled.
BMI ≥ 30.
In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lan Zhu
Phone
8613911714696
Email
zhu_julie@sina.com
First Name & Middle Initial & Last Name or Official Title & Degree
Juan Chen
Phone
8613521354364
Email
pumchcj@sina.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lan Zhu
Organizational Affiliation
Peking Union Medical College Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Foshan Maternal and Child Health Hospital
City
Foshan
State/Province
Guangdong
ZIP/Postal Code
528000
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yuling Wang
Phone
8613049161630
Email
wujun701121@126.com
Facility Name
The third Affiliated Hospital of Zhengzhou University
City
Zhengzhou
State/Province
Henan
ZIP/Postal Code
450052
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luwen Wang
Phone
8613607683293
Email
wangluwen688@sohu.com
Facility Name
Affiliated Shengjing Hospital of China Medical University
City
Shenyang
State/Province
Liaoning
ZIP/Postal Code
110004
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhijun Xia
Phone
8613840118800
Email
xiazhijunhosp2@sina.com
Facility Name
Peking Union Medical College Hospital
City
Beijing
ZIP/Postal Code
100730
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lan Zhu
Phone
13911714696
Email
zhu_julie@sina.com
First Name & Middle Initial & Last Name & Degree
Juan Chen
Phone
8613521354364
Email
pumchcj@sina.com
12. IPD Sharing Statement
Learn more about this trial
Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse
We'll reach out to this number within 24 hrs